| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.73B | -0.3% |
| R&D Expense | $600.0M | -6.7% |
| SG&A Expense | $2.39B | -2.9% |
| Pre-tax Income | $2.88B | -11.9% |
| Income Tax | $253.0M | -1.6% |
| Net Income | $2.59B | -13.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6.64B | -6.8% |
| Inventory | $4.95B | +0.0% |
| Current Assets | $18.83B | +9.4% |
| Total Assets | $40.88B | +6.6% |
| Current Liabilities | $13.88B | +6.8% |
| Long-term Debt | $5.40B | -9.6% |
| Stockholders' Equity | $18.83B | +11.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.81B | +14.3% |
| Investing Cash Flow | -$2.04B | -101.2% |
| Financing Cash Flow | -$1.48B | +2.9% |